• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Apoptosis and Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.

作者信息

Peng Z, Tang H, Ling Y, Han G

机构信息

Department of General Surgery, Shanghai First People's Hospital, Shanghai 200080.

出版信息

J Tongji Med Univ. 2001;21(2):126-9, 148. doi: 10.1007/BF02888075.

DOI:10.1007/BF02888075
PMID:11523216
Abstract

To investigate the roles of apoptosis and the Fas system (Fas, Fas ligand, soluble Fas) in the process of liver cirrhosis (LC) converting into hepatocellular carcinoma (HCC), expression of Fas and Fas ligand (FasL) in 49 LC and 36 HCC samples was detected by immunohistochemical method. Apoptosis was detected by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) method. Serum soluble Fas (sFas) levels in 28 cases of LC and 27 cases of HCC were measured by enzyme-linked immunosorbent assay (ELISA) method. Compared with LC, apoptotic indices (AI) in HCC tissues were significantly reduced (P < 0.001), expression of Fas was decreased (P < 0.05), and that of FasL was increased (P < 0.05). Serum sFas levels in HCC patients were significantly higher than those in normal controls. Down-regulation of Fas expression, up-regulation of FasL expression in hepatocytes and elevation of sFas level in serum might contribute to tumor escape from immune surveillance of the body. Apoptosis and the Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.

摘要

相似文献

1
Apoptosis and Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.
J Tongji Med Univ. 2001;21(2):126-9, 148. doi: 10.1007/BF02888075.
2
Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.HBxAg在肝细胞癌中的过表达及其与Fas/FasL系统的关系。
World J Gastroenterol. 2003 Dec;9(12):2671-5. doi: 10.3748/wjg.v9.i12.2671.
3
Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).fas/ fas配体(fasL)的表达及其在肝细胞癌(HCC)浸润淋巴细胞中的作用。
J Gastroenterol. 2001 Oct;36(10):681-8. doi: 10.1007/s005350170031.
4
The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?肝细胞癌中Fas受体和配体系统的改变:肝癌细胞在体内如何逃避宿主的免疫监视?
Hepatology. 1999 Aug;30(2):413-21. doi: 10.1002/hep.510300237.
5
In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases.慢性乙型肝炎感染及相关肝脏疾病中Fas/FasL表达的原位研究
J Viral Hepat. 1997 Sep;4(5):303-7. doi: 10.1046/j.1365-2893.1997.00053.x.
6
Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.Fas/FasL在CD8+ T细胞和CD3+ Foxp3+调节性T细胞中的表达——与肝细胞癌患者循环CD8+ T细胞凋亡的关系
Asian Pac J Cancer Prev. 2014;15(6):2613-8. doi: 10.7314/apjcp.2014.15.6.2613.
7
Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.慢性乙肝和丙肝肝病中的Fas / FasL系统、白细胞介素-1β表达与细胞凋亡
J Viral Hepat. 2008 Jul;15(7):515-22. doi: 10.1111/j.1365-2893.2008.00974.x. Epub 2008 Mar 6.
8
The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.肿瘤坏死因子(TNF)-Fas配体及丙型肝炎病毒在肝细胞癌发生发展中的作用
J Clin Virol. 2005 Oct;34(2):140-6. doi: 10.1016/j.jcv.2005.02.012.
9
The role of fas/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma.Fas/Fas配体系统在肝硬化和肝细胞癌发病机制中的作用。
Hepat Mon. 2012 Nov;12(11):e6132. doi: 10.5812/hepatmon.6132. Epub 2012 Nov 3.
10
Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.肝细胞癌患者血清中可溶性Fas/APO-1(CD95)水平升高。
Clin Exp Immunol. 1998 May;112(2):166-71. doi: 10.1046/j.1365-2249.1998.00569.x.

引用本文的文献

1
The role of fas/fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma.Fas/Fas配体系统在肝硬化和肝细胞癌发病机制中的作用。
Hepat Mon. 2012 Nov;12(11):e6132. doi: 10.5812/hepatmon.6132. Epub 2012 Nov 3.
2
Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancer.Jurkat细胞中的凋亡诱导以及女性血清中的可溶性CD95水平与患宫颈癌的风险相关。
BMC Cancer. 2008 Apr 11;8:99. doi: 10.1186/1471-2407-8-99.

本文引用的文献

1
Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.肝细胞癌患者血清中可溶性Fas/APO-1(CD95)水平升高。
Clin Exp Immunol. 1998 May;112(2):166-71. doi: 10.1046/j.1365-2249.1998.00569.x.
2
Fas system and apoptosis in viral hepatitis.病毒性肝炎中的Fas系统与细胞凋亡
J Gastroenterol Hepatol. 1997 Oct;12(9-10):S223-6. doi: 10.1111/j.1440-1746.1997.tb00504.x.
3
Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines.
J Hepatol. 1996 Oct;25(4):454-64. doi: 10.1016/s0168-8278(96)80204-2.
4
An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.Fas/Apo-1(CD95)可溶性变体共有的N端结构域可在体外防止细胞死亡。
J Immunol. 1996 Jun 15;156(12):4622-30.
5
Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver.食物限制通过细胞凋亡消除大鼠肝脏中的癌前细胞,并对抗致癌作用。
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9995-9. doi: 10.1073/pnas.91.21.9995.
6
Lethal effect of the anti-Fas antibody in mice.抗Fas抗体对小鼠的致死作用。
Nature. 1993 Aug 26;364(6440):806-9. doi: 10.1038/364806a0.
7
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.CD95(APO-1/Fas)受体和配体与肝损伤的关系。
J Exp Med. 1995 Nov 1;182(5):1223-30. doi: 10.1084/jem.182.5.1223.
8
The Fas death factor.Fas死亡因子。
Science. 1995 Mar 10;267(5203):1449-56. doi: 10.1126/science.7533326.
9
A quantitative evaluation of apoptotic bodies in rat liver.大鼠肝脏中凋亡小体的定量评估。
Liver. 1988 Jun;8(3):172-7. doi: 10.1111/j.1600-0676.1988.tb00987.x.
10
Programmed cell death: apoptosis and oncogenesis.程序性细胞死亡:细胞凋亡与肿瘤发生
Cell. 1991 Jun 28;65(7):1097-8. doi: 10.1016/0092-8674(91)90002-g.